Reactivity to type I interferon is key to predict cancer immunotherapy response
Crossref DOI link: https://doi.org/10.1038/s41590-022-01278-z
Published Online: 2022-07-25
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2022-07-25
Version of Record valid from 2022-07-25
Article History
First Online: 25 July 2022